The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?

K. Brown (Denver, United States of America)

Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Session: Lumping and splitting of fibrotic interstitial lung diseases
Session type: Symposium
Number: 3770
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Brown (Denver, United States of America). The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?. International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The progressive fibrotic phenotype in fibrotic ILDs: the critical importance of observed disease behaviour
Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Year: 2019


Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004

Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?
Source: Eur Respir J, 52 (2) 1801321; 10.1183/13993003.01321-2018
Year: 2018



Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006

Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021



The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Early radiologic diagnose and assessment of lung parenchyma in patients with mild COPD and constant progressive smoking
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007


HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012


Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 578s
Year: 2007

The airspace dimension test – A new way to diagnose emphysema?
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014